Tambe said the company, a subsidiary of the Bengaluru-based Biocon Ltd, has five products in the pipeline for launch in the ...

Biocon plans to list its biosimilars business by March 2026 and aims for a double-digit market share in the U.S. for five new ...

There is market share gain compared to last year. Any biosimilar might be able to take on a four-five or six player market, ...

Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...

HYDERABAD, Jan 31 (Reuters) - Indian biopharmaceutical firm Biocon (BION.NS), opens new tab is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core ...

HYDERABAD, Jan 30 (Reuters) - Indian biopharma company Biocon (BION.NS), opens new tab reported third-quarter revenue on Thursday that fell about 3% when compared with the year-earlier period ...

Alongside margin recovery, Biocon Biologics has also gained market share, with oncology remaining a key focus area.

SMC Global Securities said that Eicher Motors has been trading within a well-defined channel, and a breakout has occurred on ...

Shares of Biocon Ltd climbed 7 per cent in Tuesday's trade, with the nearing its September 2024 high of Rs 395.65, after HSBC upgraded the stock to 'Buy' from 'Reduce' earlier. The foreign ...

Biocon Biologics CEO discusses revenue growth, market diversification, debt strategy, and impact of US pro-localisation policy.

Biocon share price today, January 31: The share price of Biocon has fallen more than 5% in the last five trading days. (Image: Freepik) The share price of Biocon rose almost 4% to an intra-day ...

HYDERABAD (Reuters) -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a ...